Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (1157)	9/13/1999 11:24:00 PM
From: JF Quinnelly	Read Replies (2) \| Respond to of 3202

Barbara Bullard is posting that the chip part of Incyte, Synteni, only amounts to 7% of the company. INCY was already around 40 a share before they acquired Synteni, so the reaction to this looks to be typically brainless. I hope we see some licensing agreements before these two companies continue to squander assets in court fees. The negativity on INCY would have a hard time getting thicker, unless someone nukes the plant. There should be plenty of time to watch for a good entry point, wait until it builds a base and begins to trend up. In the meantime, we'll enjoy the AFFX ride....